Kathryn Haviland is President and Chief Executive Officer of Blueprint Medicines Corp (BPMC). The company reported total compensation of $13,477,004 for fiscal year 2024.
| Salary | $821,363 |
|---|---|
| Bonus | $0 |
| Stock awards | $7,472,480 |
| Option awards | $4,315,144 |
| Non-equity incentive plan | $854,217 |
| Pension and non-qualified deferred compensation | $0 |
| All other compensation | $13,800 |
| Total | $13,477,004 |
A dash means the company reported no figure in that column; 0 means it reported zero. Figures are as printed, without adjustment.
Cited to the compensation disclosure Blueprint Medicines Corp filed April 24, 2025, accession 0001558370-25-005415.
| Fiscal year | Role | Salary | Bonus | Stock awards | Option awards | Non-equity incentive | Pension / NQDC | All other | Total |
|---|---|---|---|---|---|---|---|---|---|
| FY2024 | President and Chief Executive Officer | $821,363 | $0 | $7,472,480 | $4,315,144 | $854,217 | $0 | $13,800 | $13,477,004 |
| FY2023 | President and Chief Executive Officer | $782,250 | $0 | $2,953,924 | $1,962,968 | $719,670 | $0 | $13,200 | $6,432,012 |
Totals as disclosed in each year's own compensation disclosure for Blueprint Medicines Corp.
| Peer-group chief executive median | $10,957,451 |
|---|---|
| Difference from that median | $2,519,553 |
| Percentile within the disclosed peer group | 76th |
| Peers with a disclosed figure | 17 |
Medians and percentiles are computed across the peer group Blueprint Medicines Corp discloses in its own compensation disclosure.
| Named executive officer | Role | FY2024 total |
|---|---|---|
| Kathryn Haviland this page | President and Chief Executive Officer | $13,477,004 |
| Christina Rossi | Chief Operating Officer | $6,542,019 |
| Fouad Namouni | President, Research and Development | $5,497,313 |
| Percy Carter | Chief Scientific Officer | $5,132,463 |
| Michael Landsittel | Chief Financial Officer | $4,191,251 |
The company's named executive officers for fiscal year 2024, and what it reported for each. See the full Blueprint Medicines Corp compensation brief.
Kathryn Haviland's compensation sits inside Blueprint Medicines Corp's full executive and board picture — the peer group, pay against peers, incentive design and the board itself.